Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...

BEIJING - China's reform efforts to promote research and development on medical innovation and shorten the review and approval time for the launch of related drugs have provided innovation-driven ...

Globus Medical Inc. advanced stock charts by Barron's. View GMED historical stock data and compare to other stocks, and exchanges.

Toumai Robot exemplifies China's rapid ascent as a pioneer in intelligent medical innovation. At the 2025 China Medical Equipment Exhibition in Chongqing in Southwest China, artificial ...

In the dynamic landscape of healthcare innovation, the North America medical implant market emerges as a beacon of progress. With a projected annual growth rate of 6.6% in the forecast period, this ...

Shifted global discourse on vitiligo from stigma to medical urgency. 2. Elevated patient needs and disease prioritization in global health agendas. 3. Catalyzed pharmaceutical innovation through ...

Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

Globus Medical has merged its business with NuVasive. The combined global musculoskeletal company is focused on rapid innovation, addressing unmet clinical needs and improving offerings to ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $88.00. The company’s shares closed last Friday ...

Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...